Since the first sequencing of the human genome in 2003, tremendous gains have been made in understanding hereditary cancer syndromes, with over 50 having been identified. Non-invasive tests to assess a person’s inherited risk of developing certain cancers are abundant. However, genetic tests to diagnose cancer have been much more difficult to develop. By unlocking the hidden genome, Orbit Genomics is taking precision medicine one step further in developing cancer diagnostics.
For more information (animation)